Literature DB >> 25169505

Clinicopathologic features and molecular subtypes of breast cancer in young women (age ≤35).

Sema Sezgin Goksu1, Didem Tastekin, Deniz Arslan, Seyda Gunduz, Ali Murat Tatli, Dilek Unal, Derya Salim, Tunc Guler, Hasan Senol Coskun.   

Abstract

INTRODUCTION: Breast cancer in young women is a relatively rare disease; however it tends to be more aggressive and is the leading cause of cancer death in this population. The aim of this study is to investigate the clinical and biological features of breast cancer arising in young Turkish breast cancer patients.
MATERIALS AND METHODS: Patients with breast cancer aged 35 or less (≤35 years) were selected for the study. In total 211 cases were included. Pathologic features; histologic subtypes, grade, lymphovascular invasion, axillary involvement, and stage were recorded for each.
RESULTS: The most common subtype was luminal B (36.5%), followed by luminal A (30.8%), triple negative (23.2%) and HER2+(9.5%) subtypes. Twelve percent of the patients had stage 4, 32.7% had stage 3, 46.4% had stage 2, and 6.2% had stage 1 disease at the time of diagnosis. Mean tumour diameter was 3.87 cm (range 0.3-13 cm). The axillary lymph nodes were positive in 74.4% of the patients, while lympho-vascular invasion was seen in 56.4%. Some 9.5% of patients had grade 1, 51.2% had grade 2, and 31.8% had grade 3 tumors.
CONCLUSIONS: Young women with breast cancer in Turkey are more likely to present with luminal B subtype. Tumors in young women are more likely to present with advanced disease, to be high grade and and to have more lymphovascular invasion. Further research should focus on whether we need new treatment strategies for young patients with breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25169505     DOI: 10.7314/apjcp.2014.15.16.6665

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  13 in total

Review 1.  Breast cancer: an update on treatment-related infertility.

Authors:  Erica Silvestris; Miriam Dellino; Paola Cafforio; Angelo Virgilio Paradiso; Gennaro Cormio; Stella D'Oronzo
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-31       Impact factor: 4.553

2.  Comparison of Clinical and Pathological Differences of Breast Cancer Patients under 35 and above 55 Years of Age.

Authors:  Mustafa Emiroğlu; Cem Karaali; İsmail Sert; Semra Salimoğlu; Levent Uğurlu; Süleyman Aksoy; Cengiz Aydın
Journal:  J Breast Health       Date:  2015-07-01

3.  Prognostic effect analysis of molecular subtype on young breast cancer patients.

Authors:  Hong-Liang Chen; Ang Ding; Fu-Wen Wang
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

Review 4.  Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.

Authors:  Suet Kee Loo; Megan E Yates; Sichun Yang; Steffi Oesterreich; Adrian V Lee; Xiao-Song Wang
Journal:  Genes Chromosomes Cancer       Date:  2022-02-17       Impact factor: 5.006

5.  Comparison of Molecular Subtypes of Carcinoma of the Breast in Two Different Age Groups: A Single Institution Experience.

Authors:  Pooja Gupta; Naresh N Rai; Lakshmi Agarwal; Swati Namdev
Journal:  Cureus       Date:  2018-06-18

6.  Glyphosate Primes Mammary Cells for Tumorigenesis by Reprogramming the Epigenome in a TET3-Dependent Manner.

Authors:  Manon Duforestel; Arulraj Nadaradjane; Gwenola Bougras-Cartron; Joséphine Briand; Christophe Olivier; Jean-Sébastien Frenel; François M Vallette; Sophie A Lelièvre; Pierre-François Cartron
Journal:  Front Genet       Date:  2019-09-27       Impact factor: 4.599

Review 7.  Managing breast cancer in younger women: challenges and solutions.

Authors:  Foluso O Ademuyiwa; Amy Cyr; Jennifer Ivanovich; Maria A Thomas
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-12-21

8.  Clinicopathological features and survival of early stage breast cancer in northwest China: A population-based retrospective study of 1287 patients.

Authors:  Shuting Li; Xiangtang Wang; Jiao Yang; Meng Lv; Xiao Zhang; Chunli Li; Lingxiao Zhang; Yanwei Shen; Xiaoman Zhang; Zheling Chen; Fan Wang; Xin Wang; Dan Li; Min Yi; Jin Yang
Journal:  Thorac Cancer       Date:  2017-10-04       Impact factor: 3.500

9.  Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance.

Authors:  Li Li; Ling Lin; Jamunarani Veeraraghavan; Yiheng Hu; Xian Wang; Sanghoon Lee; Ying Tan; Rachel Schiff; Xiao-Song Wang
Journal:  Breast Cancer Res       Date:  2020-08-08       Impact factor: 6.466

10.  A Novel Neoplastic Fusion Transcript, RAD51AP1-DYRK4, Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers.

Authors:  Chia-Chia Liu; Jamunarani Veeraraghavan; Ying Tan; Jin-Ah Kim; Xian Wang; Suet Kee Loo; Sanghoon Lee; Yiheng Hu; Xiao-Song Wang
Journal:  Clin Cancer Res       Date:  2020-11-10       Impact factor: 13.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.